Clorazepate Dipotassium
Product Images NDC 67046-906

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 67046-906). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7.5 mg Tablets (7abac94c Ba0e 415b 9196 72caf153cc7c 01)

Packaging label for Clorazepate Dipotassium 7.5 mg tablets, supplied in a 30-count blister card. The label includes dosage information advising to see the insert for usual dosage and storage conditions. It is labeled as a controlled substance with a sample lot and expiration date. The product is packaged by Contract Pharmacy Services-PA, with their address listed. The blister card has numbered blister cavities for each tablet, arranged for daily use tracking.*

FDA Label Image

Chemical Structure (7abac94c Ba0e 415b 9196 72caf153cc7c 02)

Chemical structure of Clorazepate Dipotassium showing the benzodiazepine core with a chlorine substituent, and potassium salt components, along with associated functional groups including amide and carboxylate moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.